NIH Patents and Patent Applications

This list includes non-provisional and PCT patent filings.

Download a CSV of all Patent records.

For information on patent application codes, country codes, and patent status, see the Patents FAQ.

Tips:
Reset Search to show all records.
Sort columns by clicking on the blue column headers.
The Search function searches across all columns.
To filter results by Lead IC, Country, or Application, type or use the dropdown menu.

Lead IC Reference Number Title Country Patent Application Type Application Number Date Filed Patent Number Date Issued Patent Status Patent PDF
NCI E-103-2007-0-PCT-02 Improved DNA Vaccination Protocols PCT PCT PCT/US2008/051004 Expired
NCI E-059-2007-2-CA-03 GP100-SPECIFIC T CELL RECEPTORS AND RELATED MATERIALS AND METHODS OF USE CA National Stage 2674445 Abandoned
NCI E-059-2007-2-CH-08 GP-100 SPECIFIC T CELL RECEPTORS AND RELATED MATERIALS AND METHODS OF USE CH EP 08727582.2 Abandoned
NCI E-059-2007-2-GB-11 GP-100 SPECIFIC T CELL RECEPTORS AND RELATED MATERIALS AND METHODS OF USE GB EP 08727582.2 Abandoned
NCI E-059-2007-2-DE-09 GP-100 SPECIFIC T CELL RECEPTORS AND RELATED MATERIALS AND METHODS OF USE DE EP 08727582.2 Abandoned
NCI E-059-2007-2-FR-10 GP-100 SPECIFIC T CELL RECEPTORS AND RELATED MATERIALS AND METHODS OF USE FR EP 08727582.2 Abandoned
NCI E-059-2007-2-EP-04 GP-100 SPECIFIC T CELL RECEPTORS AND RELATED MATERIALS AND METHODS OF USE EP National Stage 08727582.2 Abandoned
NCI E-059-2007-2-AU-02 GP100- SPECIFIC T CELL RECEPTORS AND RELATED MATERIALS AND METHODS OF USE AU National Stage 2008206442 Abandoned
NIAID E-046-2007-0-PCT-02 Universal And Specific Quantitative Detection Of Clostridium Botulinum PCT PCT PCT/US2008/050872 Expired
NCI E-059-2007-2-PCT-01 GP-100 SPECIFIC T CELL RECEPTORS AND RELATED MATERIALS AND METHODS OF USE PCT PCT COMB PCT/US08/050841 Expired
NIDDK E-021-2007-0-PCT-02 METHOD TO IDENTIFY INHIBITORS OF CELL SICKLING PCT PCT PCT/US2008/000427 Expired
NIAID E-323-2005-2-JP-07 Vaccines Against Potential Pandemic Strains of Influenza JP National Stage 2008-500042 Abandoned
NIAMS E-011-2007-0-US-02 Blockade of TL1A-DR3 Interactions to Ameliorate T Cell Mediated Disease Pathology US ORD 11/972,395 Abandoned
NCI E-086-1999-0-US-08 Molecular Diagnosis of Disseminated Candida Albicans Infection Using Hemoglobin-Response Gene US DIV 11/971,454 Abandoned
NCATS E-055-2008-0-US-01 Phosphodiesterase Inhibitors US 61/020,079 Abandoned
NCI E-083-2007-0-AU-03 SLCO1B3 GENOTYPE AU National Stage 2008205330 Abandoned
NCI E-083-2007-0-FR-08 SLCO1B3 GENOTYPE FR EP 08713083.7 Abandoned
NCI E-083-2007-0-DE-07 SLCO1B3 GENOTYPE DE EP 08713083.7 Abandoned
NCI E-083-2007-0-GB-09 SLCO1B3 GENOTYPE GB EP 08713083.7 Abandoned
NCI E-083-2007-0-EP-05 SLCO1B3 GENOTYPE EP National Stage 08713083.7 Abandoned
NCI E-083-2007-0-PCT-02 SLCO1B3 GENOTYPE PCT PCT PCT/US2008/000310 Expired
NCI E-083-2007-0-CA-04 SLCO1B3 GENOTYPE CA National Stage 2674788 Abandoned
NCI E-137-2005-0-US-03 METHODS AND COMPOSITIONS FOR TREATING FUS1 RELATED DISORDERS US National Stage 11/988,427 Abandoned
NIAID E-263-2005-0-US-03 Targeting Poly-Gamma-DL-Glutamic Acid To Treat Staphylococcus Epidermidis And Related Infections US National Stage 11/994,984 Abandoned
NCI E-241-2007-0-US-01 DETECTION OF HEREDITARY PROSTATE CANCER US 61/010,209 Abandoned
NCI E-043-2008-0-US-01 ANTI-HIV DOMAIN ANTIBODIES AND METHOD OF MAKING AND USING SAME1 US 61/019,426 Abandoned
NCI E-009-2008-0-US-01 EUKARYOTIC CELL COMPOSITIONS AND METHODS FOR PRODUCING RECOMBINANT PROTEIN IN A CELL US 61/019,562 Abandoned
NINDS E-251-2005-0-JP-06 SYSTEMS AND METHODS FOR RECOVERY OF MOTOR CONTROL VIA STIMULATION TO A SUBSTITUTED SITE TO AN AFFECTED AREA JP National Stage 2008-520302 Issued
NCI E-064-2008-0-US-01 Epoxy-guaiane Selective Renal Cancer Inhbitors US 61/018,938 Abandoned
NIAAA E-092-2006-0-US-01 Ketone Esters Or Oligomers US 61/018,962 Abandoned
NIAID E-217-2004-0-US-05 SAFER ATTENUATED VARICELLA-ZOSTER VIRUS VACCINES WITH MISSING OR DIMINISHED LATENCY OF INFECTION US National Stage 11/630,147 8916175 Issued PDF
NIAID E-056-2005-0-US-03 Porcine Rotavirus Reassortant Compositions US National Stage 11/994,645 Abandoned
NHLBI E-209-2007-0-US-01 MRI GUIDEWIRE US 61/006,265 Abandoned
NCI E-315-2007-0-US-01 Novel Natural Product Inhibitors Of ABCG2 US 61/018,758 Abandoned
NIBIB E-223-2005-0-US-07 A Spatially Selective, Fixed Optics Multicolor Flourescence Detection System For A Multichannel Plastic Microfluidic Device US National Stage 11/993,852 7924425 Abandoned PDF
NCI E-254-1999-0-US-04 New Tumor Suppressor Gene, p47ING3 US DIV 11/962,906 7709609 Abandoned PDF
NIAID E-233-2003-1-US-20 Inhibition Of HIV-1 Replication By Disruption Of The Processing Of The Viral Capsid-Spacer Peptide 1 Protein US DIV 11/962,315 Abandoned
NHGRI E-167-2001-1-US-04 Hematopoietic Stem Cells Regenerate Infarcted Myocardium US CON 11/961,537 8343479 Expired PDF
NCI E-057-1997-0-US-44 PSEUDOMONAS EXOTOXIN A-LIKE CHIMERIC IMMUNOGENS US CON 11/962,007 8092809 Abandoned PDF
NCI E-021-1996-0-US-06 METHODS AND COMPOSITIONS FOR MONITORING DNA BINDING MOLECULES IN LIVING CELLS US DIV 12/004,694 8058395 Expired PDF
NIA E-092-2004-0-US-03 Anti-Marinobufagenin Antibodies and Methods For Their Use US National Stage 11/993,309 8038997 Issued PDF
NIDA E-223-2000-0-JP-16 Coil For Magnetic Stimulation JP DIV 2007-328706 Expired
NINDS E-251-2005-0-US-07 Enhance Recovery Of Voluntary Swallowing Using Patient Control Of Vibro-tactile Stimulation To The Neck In Persons With Dysphagia Resulting From A Neurological Diseases Or Disorders US National Stage 11/993,094 8579839 Issued PDF
NIAID E-095-2000-4-US-07 Amelioration of Inflammatory Arthritis Targeting the Pre-Ligand Assembly Domain (PLAD) Of Tumor Necrosis Factor Receptors US National Stage 11/922,547 Abandoned
NHLBI E-211-2002-1-US-02 IL-21 as a Regulator of Immunoglobin Production US CON 11/958,540 Abandoned
NIBIB E-071-1997-0-JP-11 Method Utilizing Convex Geometry For Laser Capture Microdissection JP DIV 2007-290203 Abandoned
NHGRI E-149-2005-0-US-02 Methods And Materials For Identifying Polymorphic Variants, Diagnosing Susceptibilities, And Treating Disease US National Stage 11/958,126 7879551 Abandoned PDF
NHLBI E-240-1998-0-US-06 Method for Enhancing Contrast in Images Produced by Magnetic Resonance Imaging US DIV 12/002,553 Abandoned
NIAID E-070-2007-2-PCT-01 HUMAN CANCER THERAPY USING ENGINEERED MATRIX METALLOPROTEINASE-ACTIVATED ANTHRAX LETHAL TOXIN THAT TARGETS TUMOR VASCULATURE PCT PCT COMB PCT/US2007/087664 Expired
NCI E-009-1998-2-US-04 CDNA ENCODING A GENE BOG (B5t OVER-EXPRESSED GENE) AND ITS PROTEIN PRODUCT US DIV 11/956,680 Abandoned